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Aim To identify risk factors for pneumothorax treated with a chest tube after cardiac pacing device implantation in a
population-based cohort.
Methods
and results
A nationwide cohort study was performed based on data on 28 860 patients from the Danish Pacemaker Register,
which included all Danish patients who received their first pacemaker (PM) or cardiac resynchronization device from
1997 to 2008. Multiple logistic regression was used to estimate adjusted odds ratios (aOR) with 95% confidence
intervals for the association between risk factors and pneumothorax treated with a chest tube. The median age
was 77 years (25th and 75th percentile: 69–84) and 55% were male (n ¼ 15 785). A total of 190 patients (0.66%)
were treated for pneumothorax, which was more often in women [aOR 1.9 (1.4–2.6)], and in patients with age
.80 years [aOR 1.4 (1.0–1.9)], a prior history of chronic obstructive pulmonary disease [aOR 3.9 (1.6–9.5)], im-
plantation of a dual-chamber PM [aOR 1.5 (1.0–2.2)], venous access with subclavian vein puncture [aOR 7.8
(4.9–12.5)], venous access with both subclavian vein puncture and cephalic vein cut-down [aOR 5.7 (3.0–10.8)],
and implantation in a non-university centre [aOR 2.1 (1.6–2.9)].
Conclusion Pneumothorax treated with a chest tube remains a clinically important problem in device therapy. The cephalic vein
cut-down technique should be applied whenever possible to avoid this complication.
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Introduction
For decades, cardiac pacemakers (PMs) have been the treatment of
choice for bradyarrhythmias, and the use of cardiac resynchroniza-
tion therapy devices (CRT-P) has emerged. Pacemaker and CRT-P
implantations are considered to be safe procedures and serious
complications are relatively rare. However, pneumothorax follow-
ing PM and CRT-P implantation causes excess patient morbidity,
and increases cost substantially.1 If tension pneumothorax devel-
ops the situation is life threatening (Figure 1).2 Existing literature
shows variation in the incidence of pneumothorax, which may
reflect statistical imprecision due to small sample sizes, and differ-
ences in the clinical recognition of pneumothorax.1,3,4 A higher
incidence of pneumothorax has been linked to venous access
with subclavian vein puncture.5,6 Also, it has been suggested that
older age, female gender, and operator inexperience increase the
risk of pneumothorax after device implantation, primarily in
smaller studies with inconclusive results.3,7 This study aims (i) to
describe the incidence of pneumothorax after PM and CRT-P im-
plantation among all primary PM and CRT-P implantations in
Denmark during a 12-year study period and (ii) to identify
patient- and procedure-related risk factors for pneumothorax.
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Methods
Study design
A large, nationwide, population-based cohort study was performed
based on data from the Danish Pacemaker Register (DPR).
All patients who underwent primary PM or CRT-P implantation
from January 1997 to December 2008 were identified.
The Danish Pacemaker Register
Since 1982, the DPR has been the Danish national register for cardiac
pacing, and it holds data on all device implantations and replacement
procedures. The implanting cardiologist records details regarding the
implantation procedure, technical specifications, and patient-related
factors. Since 1997, details regarding in-hospital complications after
primary PM and CRT-P implantations have been prospectively
reported to the DPR by the implanting centres. If the register did
not receive a complication status for each patient a reminder was
sent to the implanting centre, which led to a yearly response rate of
97%. In Denmark, with a population of 5.6 million citizens, cardiac
device treatment is centralized in 13 centres and all procedures are
performed by cardiologists except for a small fraction of mainly paedi-
atric epicardial device implantations performed by thoracic surgeons.
During a period of 30 years, all implanting centres have been dedicated
participants of the DPR. Regular meetings between the centres and the
DPR ensure a constant focus on the reporting of complete and accur-
ate data to the register.
The National Hospital Discharge Register
The National Hospital Discharge Register (NHDR) has recorded na-
tionwide data on all hospital admissions, diagnoses, and treatments
since 1977. All outpatient visits have been included from 1995
onwards. Diagnoses and procedures are coded by the treating phys-
ician according to the International Classification of Disease (8th revi-
sion until 1993 and 10th revision thereafter).
We identified patients with a prior history of chronic heart failure
(CHF), and a prior history of chronic obstructive pulmonary disease.
We used the Charlson comorbidity index (CCI) to establish a
measure for known comorbidity prior to device implantation. This
index, which includes 19 major disease categories, has been validated
based on hospital discharge diagnoses.8 A CCI score was computed
and further divided into three comorbidity groups: 0 (‘low’), corre-
sponding to no registered comorbidity; 1–2 (‘medium’); and 3 or
above (‘high’).
The Danish Civil Registration System
The Civil Registration System (CRS) is the national register of all
Danish citizens and administers the unique personal identification
number assigned to each Danish citizen at birth. This Civil Registration
Number was used to link data from the DPR, the NHDR, and the CRS.
The CRS contains information on date of death.
Study outcome
The outcome of this study was pneumothorax requiring a chest tube
after PM or CRT-P implantation.
Risk factors
Variables selected a priori that may be associated with pneumothorax
after device implantation included gender, age, indication for device im-
plantation [atrioventricular (AV) block, sinus node dysfunction, atrial
fibrillation with bradycardia, CHF, or other], prior history of CHF,
prior history of chronic obstructive pulmonary disease, device type
(single lead atrial, single lead ventricular, dual-chamber device, or
CRT-P device), centre type (university centres, which also implanted
cardioverter-defibrillator devices, or non-university centres), operator
experience (total number of procedures: 0–24, 25–49, 50–99, or
.100), procedure type (elective or urgent), venous access (cephalic
vein cut-down, subclavian vein puncture, both cephalic vein
cut-down and subclavian vein puncture, or other), and procedure
duration.
Venous access, chest radiography, and chest
tube insertion
In Denmark, the main methods used for venous access are subclavian
vein puncture or cephalic vein cut-down. The choice is at the opera-
tor’s discretion. Most Danish cardiologists attempted to use cephalic
vein cut-down whenever possible, even more so in the second half
of the study period. However, when implanting a dual-chamber
device or a CRT-P device, some operators preferred to use both ceph-
alic vein cut-down and subclavian vein puncture without exploring the
possibility for more than one lead to enter through the cephalic vein.
The protocol for chest radiography after device implantation dif-
fered between centres and during the study period. In the beginning
of the study period, most centres routinely performed chest radiog-
raphy after all procedures. Later, many centres reserved the use of
chest radiography to patients with leads inserted with subclavian
vein puncture. Some centres and cardiologists decided on a
case-by-case basis. In the case of symptoms of pneumothorax, chest
radiography was always instigated, as supported by a study from 1990.9
Thoracic surgeons handled the chest tube insertion in university
centres, while gastrointestinal or orthopaedic surgeons usually per-
formed the procedure in non-university centres.
Statistical analysis
The Student’s t-test or the x2 test was used to evaluate the differences
between groups. Spearman’s test for trend was used to test differences
in ordered categorical variables. Multiple logistic regression analysis
was used to estimate odds ratios adjusted for a priori-selected
Figure 1 An 84-year-old man admitted to hospital due to
syncope and third-degree atrioventricular block underwent
acute implantation of a dual-chamber device, both leads inserted
with subclavian vein puncture. After the implantation, the patient
developed tension pneumothorax and a chest tube was inserted.
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confounders including age, gender, centre type, procedure date, and
device type. We chose not to adjust for procedure duration because
we judged it to be an intermediate factor rather than a confounder.
Odds ratios were presented with 95% confidence intervals. A P
value (two-sided) ,0.05 was considered statistically significant.
STATA software (STATA IC for Windows, version 11.0) was used
for all statistical analyses.
The Danish Data Protection Board approved the study. According
to Danish law no informed consent was required.
Results
Study population
Eligible study candidates were patients undergoing primary PM or
CRT-P implantation from 1997 to 2008 (n ¼ 29 846). Patients
without a reported complication status (n ¼ 787) were excluded,
as were those with two separate pacing systems for the purpose
of biventricular pacing (n ¼ 3). Patients treated in Greenland
(n ¼ 196) were excluded, because choices regarding pacing
mode and follow-up were adjusted to local conditions. This led
to a study population of 28 860 consecutive patients.
Patient and procedural characteristics
Clinical, demographic, and procedure-related characteristics are
summarized in Table 1. The majority of patients were male, and
most patients received a dual-chamber pacing device. Atrioven-
tricular block was the most common indication for device implant-
ation. The mean annual procedure number for non-university
centres was 132 (range 89–206), and for university centres 289
(range 249–339). In Table 2, venous access according to device
type is summarized. Venous access in CRT-P device implantations
nearly always included at least one subclavian vein puncture. The
proportion of venous access with subclavian vein puncture
remained stable throughout the study period. In contrast, venous
access with cephalic vein cut-down increased from 46% in 1997
to 53% in 2008, while venous access with both subclavian vein
puncture and cephalic vein cut-down dropped from 12 to 5%
during the same period.
Risk of pneumothorax
The incidence of pneumothorax requiring a chest tube was 0.66%
(n ¼ 190). The incidence fluctuated from year to year (range 0.3–
1.2%), but overall the incidence declined during the study period
(P value for trend ¼ 0.01). The risk of pneumothorax according
to patient- and procedure-related characteristics is shown in
Table 3. No fatalities were seen due to a recognized pneumo-
thorax, and no difference in 30-day all-cause mortality was
observed between patients with and without a chest tube-treated
pneumothorax (P ¼ 0.7).
Risk factors
The following risk factors were identified in crude analyses: female
gender, age .80 years, prior history of chronic obstructive pulmon-
ary disease, implantation in a non-university centre, longer procedure
duration, venous access with subclavian vein puncture, and with both
subclavian vein puncture and cephalic vein cut-down (Table 3). In
multivariate analyses, we identified the following independent risk
factors: female gender, age .80 years, prior history of chronic ob-
structive pulmonary disease, implantation of a dual-chamber device,
implantation in a non-university centre, longer procedure duration,
venous access with subclavian vein puncture, and with both
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Patient and procedure characteristics. The
Danish Pacemaker Register 1997–2008, n 5 28 860a
Characteristics No. %
Male gender 15 785 55
Age, median (years) 77 (69–84)
Age group
0–19 179 0.6
20–59 3134 11
60–79 14 111 49
80– 11 436 40
Indication
Atrioventricular block 11 753 41
Sinus node dysfunction 6655 23
Atrial fibrillation and bradycardia 4892 17
Chronic heart failure 925 3
Other 4635 16
Chronic heart failure 5742 20
Chronic obstructive pulmonary disorder 227 1
Charlson comorbidity index
Low 11 134 39
Medium 11 885 41
High 5841 20
Device type
Single lead atrial device 2771 10
Single lead ventricular device 7765 27
Dual-chamber device 17 399 60
Cardiac resynchronization therapy device 925 3
Centre type
Non-university centre 11 573 40
University centre 17 287 60
Operator experienceb
0–24 2253 8
24–49 1720 6
50–99 2018 7
100– 22 869 79
Procedure type
Elective 26 045 90
Urgent 1402 5
Missing 1413 5
Venous access technique
Cephalic vein cut-down 13 453 47
Subclavian vein puncture 12 260 42
Both cephalic vein cut-down and subclavian
vein puncture
2353 8
Other 85 0.3
Missing 709 2
aResults are presented as n (%), unless otherwise indicated. Medians are presented
with 25th and 75th percentiles.
bNumber of prior procedures.
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subclavian vein puncture and cephalic vein cut-down. No significant
association between operator experience and risk of pneumothorax
was found, but implantation by an inexperienced operator with ,25
prior procedures tended to increase the risk of pneumothorax.
Discussion
Risk of pneumothorax
The incidence of pneumothorax found in this study is similar to
previous findings.5,6,10,11 Some studies have, however, found
higher incidences which may reflect a lower threshold for chest
tube insertion, or a higher proportion of subclavian vein punctu-
res.3,7,12 Several studies lack information on treatment of the
pneumothorax (i.e. conservative, chest tube insertion), which
makes any comparisons difficult.1,4,13 The National Cardiovascular
Data Registry ICD Registry reports the risk of pneumothorax to be
0.5%,14 slightly lower than in the present study. This is likely
explained by a higher frequency of women in the present study.
Risk factors
As expected, subclavian vein puncture was strongly associated with
the risk of pneumothorax, as was venous access with both sub-
clavian vein puncture and cephalic vein cut-down. Results from
other studies support these findings.6,7 Another way of accessing
the venous system is via the axillary vein, and the risk of pneumo-
thorax is reported to be low.15,16 Access via the axillary vein,
however, often requires venography and the risk of pneumothorax
seems to rise if no venography is used.15 In Denmark, venous access
via the axillary vein is rarely used, probably because of extensive ex-
perience with both subclavian vein puncture and cephalic vein
cut-down, and a stable low absolute risk of pneumothorax. A
review on venous access from 2007 concluded that ‘no technique
is universally optimal’.17 Based on our results, however, cephalic
vein cut-down is preferable to subclavian vein puncture as venous
access whenever possible to reduce the risk of pneumothorax. Fur-
thermore, the risk of subclavian crush syndrome is increased when
subclavian vein puncture is used for venous access.18
Implantation in a non-university centre was associated with a
higher risk of pneumothorax. Operators in non-university hospitals
perform a lower number of implantations as compared with opera-
tors in university centres, which may explain this association. Dif-
ferent thresholds for chest tube insertion may bias the association.
The risk of pneumothorax was higher after implantation of a dual-
chamber device, undoubtedly due to a higher proportion of sub-
clavian vein punctures. No association was found between risk of
pneumothorax and implantation of a dual-chamber device after con-
trolling for venous access. We observed no excess risk of pneumo-
thorax after implantation of a CRT-P device, even though most
patients had at least one subclavian vein puncture. This may be
because almost all of these implantations were performed by very
experienced, high-volume operators in university centres.
Patients with a prior history of chronic obstructive pulmonary
disease had a higher risk of pneumothorax. Usually, patients with
chronic obstructive pulmonary disease have more severe symptoms
when suffering from a pneumothorax than patients without chronic
obstructive pulmonary disease.19 Because symptoms are one of the
criteria for chest tube insertion20 this may lead to a higher rate of
recognition and chest tube insertion in this group. However, it is
well known that chronic obstructive pulmonary disease increases
the risk of spontaneous pneumothorax,21 so it is plausible that
patients with chronic obstructive pulmonary disease have a true
higher risk of pneumothorax after device implantation.
Age .80 years was associated with a higher risk of pneumo-
thorax in accordance with a previous study.7 Age between 20
and 59 tended to increase the risk as well. This is likely explained
by a higher proportion of subclavian vein puncture in this group, as
no increased risk of pneumothorax was observed in the younger
patient group in the multivariate analysis when controlling for
venous access route. The risk estimate for age .80 years
remained unchanged after controlling for venous access route. Fur-
thermore, a higher risk of pneumothorax was observed in female
patients, which is in agreement with recent studies.14,22 Anatomical
differences may explain these findings, i.e. smaller body size, but in
the present study, we have no information to investigate this
further. In these patients, it may be considered to use an additional
modality to visualize the veins (i.e. venography or ultrasound)
before device implantation. Furthermore, this approach might be
considered routinely in low-volume centres or when the implant-
ation is performed by an inexperienced operator.
Longer procedure duration was an independent risk factor, but
this finding should be interpreted with caution because procedure
duration may well be an intermediate factor linking an actual risk
factor with lead complications. For instance, dual-chamber device
implantation increases the procedure duration. Furthermore,
longer procedure duration may reflect difficulty in obtaining
venous access as well as other difficulties during the implantation.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Venous access technique according to device type. The Danish Pacemaker Register 1997–2008, n5 28 860
Device type Subclavian vein
puncture
Cephalic vein
cut-down
Both subclavian vein puncture
and cephalic vein cut-down
Other Missing
Single lead atrial device 1124 (41) 1565 (56) 0 (0) 8 (0.3) 74 (3)
Single lead ventricular device 3045 (39) 4469 (58) 0 (0) 38 (0.5) 213 (3)
Dual-chamber device 7455 (43) 7415 (43) 2069 (12) 39 (0.2) 421 (2)
Cardiac resynchronization
therapy device
636 (69) 4 (0.4) 284 (31) 0 (0) 1 (0.1)
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Table 3 Risk factors for pneumothorax after pacemaker implantation. The Danish Pacemaker Register 1997–2008,
n 5 28 860
Risk cOR aORa (95% CI) P
Gender
Maleb 0.5 1.0 1.0
Female 0.9 1.9 1.9 (1.4–2.6) ,0.001
Age group
0–19 0.0 – –
20–59 0.7 1.3 1.4 (0.9–2.3) 0.15
60–79b 0.6 1.0 1.0
80– 0.8 1.4 1.4 (1.0–1.9) 0.045
Indication
Atrioventricular block 0.6 0.9 0.9 (0.6–1.3) 0.47
Sinus node dysfunctionb 0.7 1.0 1.0
Atrial fibrillation and bradycardia 0.4 0.6 0.6 (0.3–1.2) 0.14
Chronic heart failure 0.7 0.9 1.8 (0.7–4.7) 0.24
Other 0.9 1.2 1.2 (0.8–1.8) 0.47
Chronic heart failure
Nob 0.7 1.0 1.0
Yes 0.5 0.7 0.7 (0.4–1.0) 0.053
Chronic obstructive pulmonary disorder
Nob 0.7 1.0 1.0
Yes 2.2 3.5 3.9 (1.6–9.5) 0.003
Charlson comorbidity index
Lowb 0.7 1.0 1.0
Medium 0.6 0.9 0.9 (0.7–1.3) 0.62
High 0.7 0.9 1.0 (0.7–1.5) 0.93
Device type
Single lead atrial device 0.7 1.3 1.2 (0.7–2.1) 0.56
Single lead ventricular deviceb 0.5 1.0 1.0
Dual-chamber device 0.7 1.4 1.5 (1.0–2.2) 0.03
Cardiac resynchronization therapy device 0.7 1.3 2.3 (1.0–5.7) 0.06
Centre type
Non-university centre 0.9 2.0 2.1 (1.6–2.9) ,0.001
University centreb 0.5 1.0 1.0
Operator experiencec
0–24 0.8 1.2 1.5 (0.9–2.5) 0.16
24–49 0.5 0.8 0.9 (0.5–1.9) 0.87
50–99 0.7 1.1 1.1 (0.7–2.0) 0.64
100–b 0.7 1.0 1.0
Procedure type
Electiveb 0.7 1.0 1.0
Urgent 0.4 0.5 0.6 (0.3–1.5) 0.30
Venous access technique
Cephalic vein cut-downb 0.2 1.0 1.0
Subclavian vein puncture 1.2 7.9 7.8 (4.9–12.5) ,0.001
Both cephalic vein cut-down and subclavian vein puncture 0.9 6.0 5.7 (3.0–10.8) ,0.001
Procedure duration, pr. 10 min – 1.1 1.2 (1.1–1.2) ,0.001
Results are presented as absolute risk (%), crude odds ratios (cOR), and adjusted odds ratios (aOR) with 95% confidence intervals (CI).
aAdjusted for: gender, age, device type, centre type, and procedure date.
bReference group.
cNumber of prior procedures.
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Study limitations
Data in the DPR were reported by the implanting centres, and com-
plications may be underreported. In 1999, an audit of the data accur-
acy and completeness was conducted. Eighty per cent of all
complications were reported, and no systematic differences were
identified between centres.23 No audit has been performed since,
and we cannot rule out that underreporting may have risen. The
centres had a high and stable yearly response rate, though, and all
centres reported every type of complication, with an inter-centre
complication risk range of 3.1–7.1%. The register was not designed
to collect data for this specific study and we lack information on
factors that may be important, e.g. body mass index and venous
pressure. Cardiac resynchronization therapy devices patients often
have a higher venous pressure which may facilitate subclavian vein
puncture. In the present study, no valid measure for venous pressure
at the time of implantation was recorded, and therefore we were
not able to include such information in the statistical analyses.
However, the DPR contains a vast number of variables, and we
were able to adjust for most important confounders.
Differences in the strategy of chest radiography after device
implantation, both between centres and cardiologists, and during
the study period, may bias the results. In patients with subclavian
vein puncture, chest radiography was more common, thereby
increasing the chance of recognizing a pneumothorax. However,
outcome in this study was restricted to patients with pneumo-
thorax requiring a chest tube, and these patients would invariably
have had symptoms precipitating chest radiography anyway. This
supposition is supported by a study from 1990.9 We therefore
believe the diagnostics of patients with a pneumothorax requiring
a chest tube to be comparable in the two groups, which means
that this limitation is of minor importance.
Exclusion of patients may introduce selection bias. However, the
patients excluded from the study due to missing complication
status had the same incidence of pneumothorax and chest tube in-
sertion after device implantation as the patients included in the
study according to data in the NHDR. Thus, we judged the exclu-
sion of these patients to be of minor importance.
No information on pneumothorax after lead revision or PM
upgrade was available in the DPR, although highly relevant. Fur-
thermore, no data on pneumothorax not requiring chest drainage
were available. However, from 2010 onwards this information has
been recorded in the DPR.
To fully understand the impact of device complications, it is
important that all implanting centres record detailed information
on complications. In addition, further population-based studies of
complications after device implantation with validation of the
data completeness and accuracy are needed.
Conclusions
The risk of pneumothorax requiring a chest tube after device
implantation is low. Venous access route seems to be the most im-
portant risk factor for pneumothorax. The cephalic vein cut-down
technique should be applied whenever possible to avoid this compli-
cation, especially if the patient has a prior history of chronic
obstructive pulmonary disease, is older, or female. Use of
venography or ultrasound to visualize the veins should be consid-
ered before device implantation in selected patients.
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Successful laser lead extraction through a stented baffle in a patient with
surgically corrected D-transposition
Siva K. Mulpuru*, Victor Pretorius , and Ulrika Maria Birgersdotter
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A 28-year-old man with a dual-chamber implantable defibrillator presented with inappropriate shocks due to lead fracture. He was
born with D-transposition, subpulmonic ventricular septal defect (VSD) and mild pulmonic stenosis. He underwent atrial septostomy
with pulmonary artery banding (Blalock–Hanlon) 3 months after birth. After this, he underwent intra-atrial baffle rerouting (Mustard’s
repair) with closure of the VSD at 3 years of age. He underwent epicardial pacemaker implantation at the age of 12 years for inter-
mittent atrioventricular block that was later upgraded to a dual-chamber ICD (Panels A and B) at the age of 22 years. Baffle stenosis
was treated with percutaneous stenting (Panel C) at the age of 18 years. Successful leaser lead extraction (Panel D) was performed with
intracardiac echocardiographic (Panel E) guidance.
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